Evidence map›Paper›PMID 40361169›Full record

ArticleBMC medicine2025

Disease and mortality trajectories of cognitively able autistic individuals in mid- and later adulthood.

Yiwei Pu, Feng Li, Tailin Zhu, Jiong Li, Wei Zhou, Lingli Zhang, Jingyu Chen, Qianlong Zhang, Tai Ren, Fei Li

Abstract read
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yiwei Pu *Department of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Feng Li *Department of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tailin Zhu *Department of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiong LiDepartment of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wei ZhouDepartment of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lingli ZhangDepartment of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jingyu ChenDepartment of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qianlong ZhangDepartment of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tai RenDepartment of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. rt@shsmu.edu.cn.
Fei LiDepartment of Developmental and Behavioural Paediatric & Child Primary Care & Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. feili@shsmu.edu.cn.

Funding

China Brain Initiative Grant STI2030-Major Projects 2021ZD0200800China Postdoctoral Science Foundation 2022M712125Guangdong Key Project 2018B030335001Innovative research team of high-level local universities in Shanghai SHSMU-ZDCX20211100National Natural Science Foundation of China 82125032, 81930095National Natural Science Foundation of China 82301729the National Natural Science Foundation of China 82204048the Science and Technology Commission of Shanghai Municipality 23Y21900500, 19410713500, and 2018SHZDZX01the Shanghai Municipal Commission of Health and Family Planning GWV-11.1-34, 2020CXJQ01, and 2018YJRC03
6 · The paper itself

Abstract

backgroundAn increasing number of autistic adults have entered their later life, but little is known about the disease trajectory in mid- and later adulthood. We aimed to examine the patterns of comorbidity progression in adults with autism spectrum disorder (ASD) that may affect their mortality.

methodsParticipants were identified from the UK Biobank study. We first identified individuals with ASD diagnosis, each of whom was randomly matched to up to 10 participants without ASD diagnosis. Cox regression was used to estimate the hazard ratio (HR) of mortality. Disease trajectory analysis was performed to investigate temporal sequencing of medical conditions and mortality associated with ASD. A multistate model was used to investigate the association patterns between ASD and three common chronic conditions: cardiovascular disease/hypertension, type 2 diabetes and disorders of lipoprotein metabolism, and depression/anxiety.

resultsThe study included 659 ASD cases (66.8% male; mean age 52.0 [SD, 8.1]) and 6590 matched non-autistic individuals. ASD were associated with a 90% higher all-cause mortality (HR, 1.90, 95% CI, 1.41-2.55) and also higher risks of 45 medical conditions across almost all body systems (all Bonferroni-adjusted P < 0.05). Trajectory analyses exhibited three clusters of medical conditions that predisposed autistic adults to excess mortality: cardiometabolic diseases, external conditions, and infectious diseases. Autistic adults showed not only an overall increased risk of progression of multimorbidity but also distinctive association patterns across different disease transitions.

conclusionsOur findings show patterns of comorbidities among autistic adults in their mid- and later adulthood, which could provide information to their caregivers to implement appropriate disease management and prevention strategies.

Indexed as

Autism Spectrum DisorderAdultAgedCardiovascular DiseasesComorbidityDisease ProgressionFemaleHumansMaleMiddle AgedUnited KingdomAutistic adultCohort studyDisease trajectoryMulticomorbidity

Identifiers

PMID40361169
PMCPMC12076977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.